Icahn again tries to invade Biogen Idec board

Spurned by biotech firm Biogen Idec last June, billionaire investor Carl Icahn hasn’t given up -- he’s proposed a new slate of board directors that he plans to nominate at the company’s next board meeting.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.